Increasing Doses of Inhaled Corticosteroids Compared to Adding Long-Acting Inhaled β 2 -Agonists in Achieving Asthma Control

Paul M. O’Byrne; Ian Naya; Anders Källén; Dirkje S. Postma; Peter J Barnes

doi:10.1378/chest.08-1018

Increasing Doses of Inhaled Corticosteroids Compared to Adding Long-Acting Inhaled β 2 -Agonists in Achieving Asthma Control — Paul M. O’Byrne (2008) | RDL Network

Increasing Doses of Inhaled Corticosteroids Compared to Adding Long-Acting Inhaled β 2 -Agonists in Achieving Asthma Control

Discussion(0)

Related publications

Clinical outcome of adding long-acting β-agonists to inhaled corticosteroids

Scientific rationale for inhaled combination therapy with long-acting β<sub>2</sub>-agonists and corticosteroids

Tolerance to the Nonbronchodilator Effects of Inhaled β<sub>2</sub>-Agonists in Asthma

Efficacy of inhaled corticosteroids in asthma☆☆☆★

p38 Mitogen-Activated Protein Kinase-γ Inhibition by Long-Acting β<sub>2</sub>Adrenergic Agonists Reversed Steroid Insensitivity in Severe Asthma